BioPharma Credit Valuation
Is BPCR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BPCR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BPCR ($0.88) is trading below our estimate of fair value ($1.26)
Significantly Below Fair Value: BPCR is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BPCR?
Key metric: As BPCR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is BPCR's PE Ratio? | |
|---|---|
| PE Ratio | 9.6x |
| Earnings | US$109.36m |
| Market Cap | US$1.05b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7.4x |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does BPCR's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 16.4x | ||
XPS XPS Pensions Group | 12x | -14.5% | UK£742.0m |
IPX Impax Asset Management Group | 10.5x | 2.5% | UK£425.5m |
TAM Tatton Asset Management | 27.1x | 11.9% | UK£417.4m |
BBGI BBGI Global Infrastructure | 16.2x | n/a | UK£893.6m |
BPCR BioPharma Credit | 9.6x | n/a | US$1.1b |
Price-To-Earnings vs Peers: BPCR is good value based on its Price-To-Earnings Ratio (9.6x) compared to the peer average (16.4x).
Price to Earnings Ratio vs Industry
How does BPCR's PE Ratio compare vs other companies in the GB Capital Markets Industry?
| 4 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
PNIX Phoenix Digital Assets | 1.2x | n/a | US$34.25m |
IX. i(x) Net Zero | 0.1x | n/a | US$8.94m |
APQ APQ Global | 0.4x | n/a | US$5.78m |
MAFL Mineral & Financial Investments | 2x | n/a | US$5.00m |
| 4 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: BPCR is good value based on its Price-To-Earnings Ratio (9.6x) compared to the UK Capital Markets industry average (12.1x).
Price to Earnings Ratio vs Fair Ratio
What is BPCR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 9.6x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BPCR's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Exor
€20.5b
Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.
0RKY
€94.30
7D
0.05%
1Y
8.2%
BFF Bank
€1.7b
Provides financial services to suppliers of the national health system and public administration sector in Italy, Croatia, the Czech Republic, France, Greece, Poland, Portugal, the Slovak Republic, and Spain.
0RON
€8.95
7D
6.2%
1Y
-10.3%
Man Group
UK£2.4b
Man Group Limited is a publicly owned investment manager.
EMGL
UK£2.09
7D
1.2%
1Y
-3.1%